Format
Sort by

Send to

Choose Destination

Links from Books

Items: 12

1.

Biomedical research in an era of unlimited aspirations and limited resources.

Fauci AS.

Lancet. 1996 Oct 12;348(9033):1002-3. No abstract available.

PMID:
8855860
2.

The politics of breast cancer.

Marshall E.

Science. 1993 Jan 29;259(5095):616-7. No abstract available.

PMID:
8430307
3.

Access to investigational drugs for treatment purposes.

Nightingale SL, Kimbrough CA, Rheinstein PH.

Am Fam Physician. 1994 Sep 15;50(4):845-7. No abstract available.

PMID:
8079913
4.

The patent craze and academia.

[No authors listed]

Lancet. 1993 Dec 11;342(8885):1435-7. No abstract available.

PMID:
7902475
5.

The slowing of treatment discovery, 1965-1995.

Wurtman RJ, Bettiker RL.

Nat Med. 1995 Nov;1(11):1122-5. No abstract available.

PMID:
7584975
6.

The FDA's new procedures for the use of investigational drugs in treatment.

Young FE, Norris JA, Levitt JA, Nightingale SL.

JAMA. 1988 Apr 15;259(15):2267-70.

PMID:
3280842
7.

FDA regulations provide broader access to unapproved drugs.

Shulman SR, Raiford DS.

J Clin Pharmacol. 1990 Jul;30(7):585-7. No abstract available.

PMID:
2391391
8.

AIDS, activism, and ethics.

Rothman DJ, Edgar H.

Hosp Pract (Off Ed). 1991 Jul 15;26(7):135-42.

PMID:
2071678
9.

AIDS vaccine trials: bumpy road ahead.

Cohen J.

Science. 1991 Mar 15;251(4999):1312-3. No abstract available.

PMID:
2003218
10.

The Orphan Drug Act. The first 7 years.

Asbury CH.

JAMA. 1991 Feb 20;265(7):893-7.

PMID:
1992188
11.

AIDs, activism, and the politics of health.

Wachter RM.

N Engl J Med. 1992 Jan 9;326(2):128-33. No abstract available.

PMID:
1727220
12.

From the Food and Drug Administration.

Nightingale SL.

JAMA. 1992 Dec 23-30;268(24):3418. No abstract available.

PMID:
1460725
Items per page

Supplemental Content

Write to the Help Desk